Mint Solutions raises Series B financing

Fraser has acted as exclusive financial advisor to Mint Solutions, developing and marketing the revolutionary medication safety system MedEye, on its €5 million Series B equity funding round led by the Brabant Development Agency (BOM Capital) and existing shareholders LSP Life Sciences Partners, investing from its LSP Health Economics Fund, and Seventure Partners.

Amsterdam – August 25, 2016. Mint Solutions Holding BV, a private Dutch company developing and marketing the revolutionary medication safety system MedEye, has raised € 5 million in a Series B equity funding round led by the Brabant Development Agency (BOM Capital) and existing shareholders LSP (Life Sciences Partners), investing from its LSP Health Economics Fund, and Seventure Partners. Other shareholders, including NSA Ventures and a number of private Icelandic investors, also participated in the financing.

The new funds will be used to support the rollout of Mint’s proprietary MedEye system, which aims to stop and prevent medication errors and improve efficiency in hospitals and care institutions. Through a combination of innovative hardware and software and seamless integration with hospital information systems, MedEye enables nurses to automatically verify medication at the bedside, thus ensuring that patients get the right medication, in the right dose and at the right time. Following successful deployment at several Dutch hospitals, Mint is preparing to expand into adjacent market segments and additional countries.

“This investment comes at a crucial time for our MedEye product. We are experiencing strong demand from Dutch hospitals and we see ample growth opportunity in other care segments, including long-term care, as well as international markets,” said Gauti Reynisson, CEO of Mint Solutions. “The new funding allows us to roll out MedEye and increase medication safety in even more hospitals and care institutions both in and outside the Netherlands.”

“The MedEye system has proven to significantly reduce medication errors, providing a great benefit for both hospitals and individual patients,” commented Miriam Dragstra, Director of BOM Capital. “We are pleased to be joining Mint Solutions now, as the company prepares to relocate its headquarters to the Brabant region to participate in the regional ecosystem around MedTech and e-health solutions.”

To mark today’s announcement, representatives from Mint Solutions and BOM visited Euronext Amsterdam this morning to attend the so-called Gong ceremony. Miriam Dragstra, Director of BOM Capital, was joined on stage by Mint Solutions CEO Gauti Reynisson and other members of the Mint and BOM team, to open trading on the Amsterdam stock exchange by sounding the Gong.

About MedEye

MedEye is an AI powered optical verification system that accurately and efficiently identifies medications at the bedside, ensuring correct medication administration and registration.  MedEye acts as a second nurse for faster and safer verification, while saving time and costs for hospitals and long-term care facilities.

About Fraser

We are a dedicated M&A advisory and investment firm, partnering with leaders in Europe’s technology sectors to unlock next levels of growth and success. Based in Berlin, London and Chicago, we advise entrepreneurs, senior management and boards on their most important strategic decisions and transactions. Alongside our clients and partners, we also invest into selected opportunities. For further information, please visit www.fraserfinance.com.